Future Medicine Ltd., part of Future Science Group, UK, has announced the launch of the new journal - Hepatic Oncology. This new title focuses specifically on the specialism of hepatic cancer, including both primary and secondary malignancies.
Hepatic Oncology is published by Future Medicine Ltd, and joins its portfolio of oncology journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.
Hepatic Oncology provides a forum to report and debate all aspects of cancer of the liver and bile ducts. The journal publishes original research studies, full reviews and commentaries, with all articles subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP2.
The direction of the journal is led by a team of three Senior Editors, Dr Jordi Bruix (University of Barcelona), Professor Richard Finn (UCLA) and Professor Ronnie TP Poon (The University of Hong Kong), along with an international Editorial Board of experts in the field.
